Position in ACET
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$826,277
+$137,548 QoQ
Shares Held
95,634
-5.4% QoQ
Ownership
1.02%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 56 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACET Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. ACET ranks #330 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in ACET
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $826,277 | 95,634 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $688,729 | 101,135 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $748,166 | 88,856 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $572,130 | 706,334 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $430,863 | 706,334 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $581,879 | 770,703 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $738,374 | 767,541 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,106,734 | 768,566 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $811,908 | 670,999 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $2,831,658 | 1,204,961 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,250,792 | 661,795 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $867,146 | 632,954 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,538,114 | 632,969 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,491,648 | 606,189 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,275,994 | 590,156 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $7,657,398 | 538,495 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,154,892 | 421,568 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $7,824,944 | 391,835 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,396,032 | 308,521 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,660,582 | 339,360 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $3,275,728 | 318,341 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,560,640 | 119,315 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $470,337 | 33,476 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $342,681 | 28,821 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||